1-12 of 12
Andrea Sartore-Bianchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer

Giorgio Patelli, Gianluca Mauri, Federica Tosi, Alessio Amatu, Katia Bencardino, Erica Bonazzina, Elio Gregory Pizzutilo, Federica Villa, Gabriele Calvanese, Alberto Giuseppe Agostara, Stefano Stabile, Silvia Ghezzi, Giovanni Crisafulli, Federica Di Nicolantonio, Silvia Marsoni, Alberto Bardelli, Salvatore Siena, Andrea Sartore-Bianchi
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4530–4539.
https://doi.org/10.1158/1078-0432.CCR-23-0079
Published: 14 November 2023
View article titled, Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
Open the PDF for Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer in another window
Journal Articles

Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer

Erika Durinikova, Nicole M. Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M. L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba, Giorgio Corti, Andrea Degasperi, Carlotta Cancelliere, Gianluca Mauri, Pietro Andrei, Michael Linnebacher, Silvia Marsoni, Salvatore Siena, Andrea Sartore-Bianchi, Serena Nik-Zainal, Federica Di Nicolantonio, Alberto Bardelli, Sabrina Arena
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3874–3889.
https://doi.org/10.1158/1078-0432.CCR-22-0875
Published: 01 September 2022
View article titled, Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Open the PDF for Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

Simona Corso, Filippo Pietrantonio, Maria Apicella, Cristina Migliore, Daniela Conticelli, Annalisa Petrelli, Laura D'Errico, Stefania Durando, Daniel Moya-Rull, Sara E. Bellomo, Stefano Ughetto, Maurizio Degiuli, Rossella Reddavid, Uberto Fumagalli, Stefano De Pascale, Giovanni Sgroi, Emanuele Rausa, Gian Luca Baiocchi, Sarah Molfino, Giovanni De Manzoni, Maria Bencivenga, Salvatore Siena, Andrea Sartore-Bianchi, Federica Morano, Salvatore Corallo, Michele Prisciandaro, Maria Di Bartolomeo, Annunziata Gloghini, Silvia Marsoni, Antonino Sottile, Anna Sapino, Caterina Marchiò, Asa Dahle-Smith, Zosia Miedzybrodzka, Jessica Lee, Siraj M. Ali, Jeffrey S. Ross, Brian M. Alexander, Vincent A. Miller, Russell Petty, Alexa B. Schrock, Silvia Giordano
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3126–3140.
https://doi.org/10.1158/1078-0432.CCR-20-0121
Published: 01 June 2021
View article titled, Optimized EGFR Blockade Strategies in <em>EGFR</em> Addicted Gastroesophageal Adenocarcinomas
Open the PDF for Optimized EGFR Blockade Strategies in <em>EGFR</em> Addicted Gastroesophageal Adenocarcinomas in another window
Includes: Supplementary data
Journal Articles

The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer

Paolo Manca, Salvatore Corallo, Adele Busico, Sara Lonardi, Francesca Corti, Carlotta Antoniotti, Letizia Procaccio, Matteo Clavarezza, Valeria Smiroldo, Gianluca Tomasello, Roberto Murialdo, Andrea Sartore-Bianchi, Patrizia Racca, Filippo Pagani, Giovanni Randon, Antonia Martinetti, Elisa Sottotetti, Federica Palermo, Federica Perrone, Elena Tamborini, Michele Prisciandaro, Alessandra Raimondi, Maria Di Bartolomeo, Federica Morano, Filippo Pietrantonio
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (9): 2505–2514.
https://doi.org/10.1158/1078-0432.CCR-20-4699
Published: 01 May 2021
View article titled, The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer
Open the PDF for The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B11: Whole-exome sequencing analysis of urine transrenal tumor DNA in metastatic colorectal cancer patients

Giovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, Monica Montone, Alice Bartolini, Ludovic Barault, Antonio Martinetti, Federica Morano, Filippo Pietrantonio, Andrea Sartore-Bianchi, Salvatore Siena, Federica Di Nicolatonio, Silvia Marsoni, Alberto Bardelli, Giulia Siravegna
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): B11.
https://doi.org/10.1158/1557-3265.LiqBiop20-B11
Published: 01 June 2020
View article titled, Abstract B11: Whole-exome sequencing analysis of urine transrenal tumor DNA in metastatic colorectal cancer patients
Journal Articles

A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin

Sabrina Arena, Giorgio Corti, Erika Durinikova, Monica Montone, Nicole M. Reilly, Mariangela Russo, Annalisa Lorenzato, Pamela Arcella, Luca Lazzari, Giuseppe Rospo, Massimiliano Pagani, Carlotta Cancelliere, Carola Negrino, Claudio Isella, Alice Bartolini, Andrea Cassingena, Alessio Amatu, Gianluca Mauri, Andrea Sartore-Bianchi, Gloria Mittica, Enzo Medico, Silvia Marsoni, Michael Linnebacher, Sergio Abrignani, Salvatore Siena, Federica Di Nicolantonio, Alberto Bardelli
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1372–1384.
https://doi.org/10.1158/1078-0432.CCR-19-2409
Published: 13 March 2020
View article titled, A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Open the PDF for A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin in another window
Includes: Supplementary data
Journal Articles

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Filippo Pietrantonio, Riccardo Lobefaro, Maria Antista, Sara Lonardi, Alessandra Raimondi, Federica Morano, Stefania Mosconi, Lorenza Rimassa, Sabina Murgioni, Andrea Sartore-Bianchi, Gianluca Tomasello, Raffaella Longarini, Gabriella Farina, Fausto Petrelli, Stefania Gori, Giovanni Randon, Salvatore Corallo, Filippo Pagani, Vincenzo Guarini, Federica Palermo, Antonia Martinetti, Marco Macagno, Ludovic Barault, Federica Perrone, Elena Tamborini, Massimo Milione, Federica Di Nicolantonio, Massimo Di Maio, Giovanni Fucà, Maria Di Bartolomeo, Filippo de Braud
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (5): 1017–1024.
https://doi.org/10.1158/1078-0432.CCR-19-3024
Published: 02 March 2020
View article titled, Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer
Open the PDF for Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

Luca Lazzari, Giorgio Corti, Gabriele Picco, Claudio Isella, Monica Montone, Pamela Arcella, Erika Durinikova, Eugenia R. Zanella, Luca Novara, Fabiane Barbosa, Andrea Cassingena, Carlotta Cancelliere, Enzo Medico, Andrea Sartore-Bianchi, Salvatore Siena, Mathew J. Garnett, Andrea Bertotti, Livio Trusolino, Federica Di Nicolantonio, Michael Linnebacher, Alberto Bardelli, Sabrina Arena
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (20): 6243–6259.
https://doi.org/10.1158/1078-0432.CCR-18-3440
Published: 15 October 2019
View article titled, Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Open the PDF for Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Giulia Siravegna, Andrea Sartore-Bianchi, Rebecca J. Nagy, Kanwal Raghav, Justin I. Odegaard, Richard B. Lanman, Livio Trusolino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3046–3053.
https://doi.org/10.1158/1078-0432.CCR-18-3389
Published: 15 May 2019
View article titled, Plasma HER2 (<em>ERBB2</em>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
Open the PDF for Plasma HER2 (<em>ERBB2</em>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

Takeo Fujii, Afsaneh Barzi, Andrea Sartore-Bianchi, Andrea Cassingena, Giulia Siravegna, Daniel D. Karp, Sarina A. Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Helen J. Huang, Silvio Veronese, Federica Di Nicolantonio, Sandeep Pingle, Cecile Rose T. Vibat, Saege Hancock, David Berz, Vladislava O. Melnikova, Mark G. Erlander, Rajyalakshmi Luthra, E. Scott Kopetz, Funda Meric-Bernstam, Salvatore Siena, Heinz-Josef Lenz, Alberto Bardelli, Filip Janku
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3657–3666.
https://doi.org/10.1158/1078-0432.CCR-16-2592
Published: 13 July 2017
View article titled, Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of <em>KRAS</em> Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers
Open the PDF for Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of <em>KRAS</em> Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers in another window
Includes: Supplementary data
Journal Articles

Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer

Alessio Amatu, Andrea Sartore-Bianchi, Catia Moutinho, Alessandro Belotti, Katia Bencardino, Giuseppe Chirico, Andrea Cassingena, Francesca Rusconi, Anna Esposito, Michele Nichelatti, Manel Esteller, Salvatore Siena
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2265–2272.
https://doi.org/10.1158/1078-0432.CCR-12-3518
Published: 15 April 2013
View article titled, Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
Open the PDF for Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, Linda Nici, James W. Darnowski, Dario Barbone, Dean A. Fennell, Giovanni Gaudino, Camillo Porta, Luciano Mutti
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5942–5951.
https://doi.org/10.1158/1078-0432.CCR-07-0536
Published: 01 October 2007
View article titled, Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent <em>In vivo</em> Activity in Mesothelioma
Open the PDF for Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent <em>In vivo</em> Activity in Mesothelioma in another window